Final Results Of The Phase I "Hit" Study: A Multicenter Phase I-Ii Study Evaluating Trastuzumab Administered By Intrathecal Injection For Leptomeningeal Meningitis Of Her2+Metastatic Breast Cancer (Mbc)
CANCER RESEARCH（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要